Health

TGA Warns of Eye Disorder Linked to GLP-1 Drugs

Updated 2026-07-24 06:55 UTC 1 source Neutral

The Therapeutic Goods Administration (TGA) in Australia issued a warning about a rare but severe eye disorder, NAION, associated with GLP-1 drugs like Ozempic. The product information for these diabetes and weight loss medications has been updated to include this new safety information.

Coverage timeline — 1 article

The Guardian

Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder<a href="https://www.theguardian.com/australia-news/live/2026/jul/24/australia-news-live-jim-chalmers-anthony-albanese-labor-conference-gas-tax-gambling-reform-one-nation-paul

2026-07-24 06:39 UTC